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drom the first time man pondered his uni-
verse, the quest to see better has never
ceased. The telescope permitted a better
view of the heavens and the earth. The mi-
roscope brought a new inner world into view. New
ays of imaging created new science. The quest
ontinues in our time and in our field of endeavor.
Imaging applied to one of the greatest advances
n cardiology, intravascular stenting, has led us to
etter results. No one would forget that the intra-
ascular ultrasound image demonstrating that the
ull apposition of the stent struts to the vessel
all reduced abrupt thrombotic occlusion and
ermitted us to stent patients without the impos-
ible task of warfarin anticoagulation and its
leeding complications (1). As a consequence, in-
erventional cardiologists now implant the more
dvanced stents routinely. However, the role of
maging became the key to understanding the
reatest downside of drug-eluting stenting,
amely abrupt thrombotic occlusion (2,3). Using
lectron microscopy, Finn et al. (4) recently dem-
nstrated that the increased number of stent
truts uncovered by endothelium was directly re-
ated to thrombotic subacute death. Ongoing im-
ging studies now describe the reconstitution of
he neoendothelium (5,6), the character of endothe-
ial dysfunction (7), and the importance of the na-
ure of underlying atherosclerotic plaque (8–10).
Imaging at the macroscopic level refers to the
odalities permitting direct visualization of thecrom the University of California, Irvine, Irvine, California.oronary artery and includes principally angiogra-
hy (including standard invasive angiography and
oninvasive computed tomography and magnetic
esonance angiography) and angioscopy. After set-
ing the stage and defining the necessity to see
ore, advances in radiographic techniques utiliz-
ng flat-panel digital systems and computed to-
ographic angiography now permit increased res-
lution to the submillimeter level and provide
nhanced images of the vessel lumen and vessel
all. These images are critically important to the
etter diagnosis of dissection, thrombus, and
laque vulnerability. Nonetheless, the inherent
imitations of radiographic resolution highlight
he inability to give microscopic information
bout the diseased vessel. Better imaging with
isible light transmitted through catheter-based
ptical fibers permits a direct macroscopic exami-
ation of the vessel surface. Using fiberoptic bun-
les incorporating 6,000 fibers with an outer di-
meter of 0.75 mm, 70° of field of view, and
mage depth ranging up to 5 mm from the tip,
ngioscopy shows fine detail of plaque topogra-
hy, cholesterol quantitation and distribution
through color intensity), and the likelihood of
uperficial thrombosis. Although confirming many
uppositions about the mechanisms of acute coro-
ary syndrome, angioscopy cannot be expected to
ield more than the luminal surface data. The re-
uirement of a blood-free field for optimal imaging
as restricted widespread use of this technique.
hile a side-viewing imaging catheter is under
evelopment, this technique will likely remain
onfined to the macroscopic world. Whether
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557ngioscopy can provide new information will de-
end on the ingenuity of investigation and the
bility to manipulate the transmitted signal light
o the vessel coupled with particular novel bio-
ogic markers (11).
On the other hand, the microscopic character-
stics of the vessel have been uncovered by high-
requency imaging using reflected ultrasound and
oherent light. Such technologies have already
roven the intimate relationship between the ath-
rosclerotic substrate and the healing response
articularly relevant to the early and late clinical
utcomes of the stented patient. Enhanced acous-
ic tomographic images using either pulse-echo
equence or vectors have resulted in improve-
ents in the resolution, depth of penetration, and
ttenuation of the acoustic tissue signature. Con-
entional intravascular ultrasound (IVUS) cathe-
ers utilize frequencies from 20 to 40 MHz with
esolution of approximately 20 to 40 m, respec-
ively. Depending on factors such as emitted pulse
ength and position of the imaging structure, ra-
ial resolution may range from 40 to 150 m. By
olor-coding ultrasound radiofrequency backscat-
er, IVUS data can be correlated to the vascular
istology of the normal and diseased arteries.
his method—virtual histology—uses algorithms
o generate a color map of the vessel structure
ontent coding for fibrous, necrotic, calcific, and
brofatty tissue (12,13). Significant correlations
etween virtual histology ultrasound frequency
aps with corresponding histopathology from in
ivo specimens have been validated by direct
therectomy (13). Likewise, the study of plaque
omposition and associated coronary artery re-
odeling in both culprit and nonculprit lesions
ave demonstrated the quantity and distribution
f thin-cap fibroatheroma thought to be the most
ulnerable, rupture prone morphology. The virtual
istology findings of a focal necrotic core 10%
ross-sectional area of the plaque without overly-
ng fibrous tissue defining the thin-cap fibroathe-
oma was significantly more prevalent in patients
ith acute rather than stable coronary syndromes
14). The current limitations of virtual histology
nclude low resolution (about 250 m), no classi-
cation for thrombus, blood, or intimal hyperpla-
ia, inability to image through calcific deposits,
nd the lack of outcome data relating virtual his- tology findings to various clinical presentations. It
s likely that the PROSPECT (Providing Re-
ional Observations to Study Predictors of
vents in the Coronary Tree) study, a natural
istory trial using 3-vessel imaging, IVUS, pal-
ography, and virtual histology in 700 acute
oronary syndrome patients with a 5-year clini-
al follow-up will address the clinical relevance
f virtual histology.
Using phased reflection analysis of the high
requencies of coherent light, a fiberoptic cathe-
er-based system can also produce tomographic
essel images. Optical coherent tomography
OCT) images have a resolution of 15 m axially
nd 25 m laterally, approximately 10-fold better
han that of the ultrasound image (15,16). While
mproved resolution is traded for less depth of
enetration, the OCT image offers new insight
nto the vessel and its surface and near surface
ubstructures. Initial OCT image acquisition was
imited by requiring prolonged vessel occlusion
nd blood replacement with an optically clear
ush solution to produce a blood-free field. To
ncrease scan image acquisition time, an optical
requency domain imaging system can now mea-
ure the optical echo time, the delay from a light
ource whose output is rapidly changed over a
ide spectrum of wavelengths. The fast Fourier
ransform algorithm permits the generation of a
requency domain or wavelength dependent data-
et and increases the image acquisition rate from
0 to 80–110 frames/s permitting comprehensive
canning of long-vessel segments during very brief
ush clearance without the need for vessel occlu-
ion (17). Clinical studies involving the thin-cap
broatheroma and neoendothelization after stent-
ng are likely to provide new information beyond
tent healing. The manuscript by Kubo et al. (18),
n this issue of iJACC (JACC: Cardiovascular Im-
ging) highlights that OCT not only allows better
efinition of vessel wall characteristics, it may
hed light on pathogenesis and prognostic out-
omes of various interventional processes. The au-
hors of this study propose that the stents may
ot find optimal apposition in vulnerable and
uptured plaques. Thus, drug-eluting stents may
ot allow optimal neointimal formation and be-
ome a nidus for delayed stent thrombosis. Al-
hough this seems to be a very logical proposal,
a
t
t
t
e
s
a
e
p
i
b
s
t
s
t
c
i
a
t
d
s
h
h
a
f
i
c
a
i
i
m
a
i
s
b
i
l
f
e
h
m
a
a
m
c
u
n
a
m
t
t
a
f
w
c
f
h
b
m
o
A
J
E
3
S
R
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 1 , N O . 4 , 2 0 0 8
J U L Y 2 0 0 8 : 5 5 6 – 9
Kern and Narula
Editor’s Page
558ll patients were on dual antiplatelet therapy and
he follow-up in their study was not long enough
o establish this presumption (18).
Incrementally to the OCT, intravascular reflec-
ance spectroscopy examines the interaction of
mitted light and chemical composition. Several
pectroscopic modalities such as near-infrared im-
ging and Raman and fluoroscopic spectroscopy
mploy diffuse reflectance to derive content of
hosphates, calcium, and cholesterol (19). Near-
nfrared spectroscopy analyzes the light absor-
ance as a function of wavelength (70 to 250 nm)
pecifically characterizing the type of material in
his spectra. A near-infrared spectroscopy catheter
ystem utilizing catheter-based fiberoptic bundles
o collect reflected light generates an image of the
holesterol spectra across the vascular surface dur-
ng catheter pullback (20), and has demonstrated
more specific chemical link to the vulnerable ar-
ery and patient.
Similarly, an intravascular catheter MRI has been
eveloped to provide a stronger contrast between the
oft tissue components previously obscured by a
igh signal to noise ratio. An intravascular MRI coil
as defined atherosclerotic plaque characteristics in
nimal models, and a miniaturized coil detector
rom a guidewire has been validated in ex vivo and
n vitro arteries (21). Although there is a theoretic
oncern regarding local heat generation by MR im-
ging, animal studies have not demonstrated safety
ssues with regard to coagulation or intimal thermal
njury (22). New approaches using catheter-based
agnets and coils could also permit stand alone im-
ging with no external scanner (23). Based on phys-
ologic data, other imaging technologies, such as in-very late stent thrombosis after drug- tissue response attress-strain relationships, may provide new insights
eyond microscopic morphology (24).
The successes of intravascular imaging techniques
n defining morphological characteristics have stimu-
ated a possibility of exploiting these technologies
or identification of molecular characteristics and the
xtent of plaque inflammation. Molecular imaging
as employed targeting with site-specific enhance-
ent with antibodies, peptides, polysaccharides, and
ptamers (25). A number of targets have included
dhesion molecules, chemotactic peptides, matrix
etalloproteinases, and cell death markers. Intravas-
ular optical and nuclear imaging is being proposed
sing targeting tracers developing on the success of
oninvasive imaging (26,27).
A desire to identify the potential lethal aspects of
therosclerotic plaques is driving investigators into
ore innovative imaging technology. Seeing more
hrough novel imaging will verify and validate pa-
hology and mechanisms. Seeing more will permit
therosclerotic researchers to identify best therapies
or better outcomes. The clinical value to medicine
ill reside in the linkage between image and out-
ome, the study of which will remain at the fore-
ront of our attack on acute and chronic coronary
eart disease. Multimodality imaging with catheter-
ased structural, microscopic signal processing and
olecular imaging will certainly fulfill at least part
f our dream to see the future.
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